Frost & Sullivan, at its 6th Annual India Healthcare Excellence Awards function held in Mumbai, presented 26 awards to companies and individuals who demonstrated best practices in the Indian healthcare and life sciences industry.

The event witnessed the presence of the who’s who in the healthcare sector, and deserving companies and individuals were felicitated for their innovative growth strategies and solutions.

The awards programme followed a rigorous methodology to recognize superior planning and execution of product launches, strategic alliances, distribution strategies, technological innovations, customer services, healthcare delivery services, and mergers and acquisitions.

Other crucial factors used to evaluate the nominees included leadership qualities, strategy, growth, service, innovation, integration, marketing, and financial performance.

Jayant Singh, director, Healthcare and Life Sciences Practice, Frost & Sullivan said, “This year, we have sought to recognize companies who have demonstrated excellence in business process innovation, service delivery innovation, and product innovation. Although currently some of them are niche, they have shown promising impact on the healthcare industry and are expected to grow at a steady pace to become well established in the near future. The award categories spanned across the breadth of the healthcare industry including medical technologies, pharmaceuticals and biotechnology and healthcare delivery services. While these award categories are identified by our team and ratified by an eminent panel of external jury members, special awards were conferred by Frost & Sullivan to leaders who have dedicated themselves toward addressing India’s pertinent healthcare challenges, making an indelible impact on this industry.”

Frost & Sullivan followed a rigorous 10-step process to conduct a detailed evaluation of the shortlisted companies for the financial year 2013-14 and identify the award recipients. This process saw external jury members, eminent personalities, and key opinion leaders in the healthcare industry rate each company across 8-10 parameters based on research data provided by Frost & Sullivan and the jury members’ own understanding of the market as a subject matter expert.